St. Mary's Hospital in Huntington, WV

St. Mary's Hospital is a medicare certified nursing home in Huntington, West Virginia. It is located in Cabell county at 2900 First Street, Huntington, West Virginia 25702. You can reach out to the office of St. Mary's Hospital via phone at (304) 526-8983. This skilled nursing facility has 19 federally certified beds with average occupancy rate of 63.16%. Its legal business name is St. Mary's Medical Center Inc and has the following ownership type - For Profit - Corporation.

St. Mary's Hospital (Medicare CCN 515113) is certified by CMS (Centers for Medicare & Medicaid Services) and participates in medicare program. This means if you are part of medicare program, you may consider this nursing facility for your medical needs. It was first certified by CMS in 1991 (33 years certified) and the last quality survey was conducted in February, 2021.

Contact Information

St. Mary's Hospital
2900 First Street, Huntington, West Virginia 25702
(304) 526-8983


Nursing Home Profile

NameSt. Mary's Hospital
Location2900 First Street, Huntington, West Virginia
Certified ByMedicare
No. of Certified Beds19
Occupancy Rate63.16%
Medicare ID (CCN)515113
Legal Business NameSt. Mary's Medical Center Inc
Ownership TypeFor Profit - Corporation

NPI Associated with this Nursing Home:

Nursing Homes may have multiple NPI numbers. We have found possible NPI number/s associated with St. Mary's Hospital from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1316918543
Organization NameST MARYS MEDICAL CENTER, INC.
Address2900 First Ave, Huntington, WV 25702
Phone Number304-526-1014

News Archive

U of I scientists show that tomato component reduces growth of prostate tumors in animal models

Years of research in University of Illinois scientist John Erdman's laboratory have demonstrated that lycopene, the bioactive red pigment found in tomatoes, reduces growth of prostate tumors in a variety of animal models. Until now, though, he did not have a way to trace lycopene's metabolism in the human body.

Bioactive lipid LPA mediates fibrogenesis in bleomycin mouse model of scleroderma

Amira Pharmaceuticals, Inc. announced today that their collaborators, Andrew Tager, M.D. and Flavia V. Castelino, M.D. of Massachusetts General Hospital, Harvard Medical School, will present a preclinical proof-of-concept study which demonstrates that the bioactive lipid lysophosphatidic acid (LPA), through its high affinity LPA1 receptor, is an important mediator of fibrogenesis in the bleomycin mouse model of scleroderma. Data will be presented as part of a poster session for the 1st Systemic Sclerosis World Congress to be held in Florence, Italy, February 11 to 13, 2010.

Study identifies new prognostic biomarker and therapeutic target for adult B-ALL

New insight into the aggressive behavior of certain adult B-acute lymphoblastic leukemias has provided researchers with a potential new prognostic biomarker and a promising new therapeutic target.

Foot fracture risk rises with childhood BMI

Body mass index is significantly associated with the risk for lower extremity fracture in children, US researchers report.

Read more Medical News

› Verified 7 days ago

Quality Ratings:

Nursing homes vary in the quality of care and services they provide to their residents. The below quality ratings for St. Mary's Hospital are calculated from three sources - health inspection results, staffing data, and quality measure data. This information gives you an indication of the care St. Mary's Hospital give to their patients.
Ratings from Surveys (Inspections):
Ratings from Quality Measures:
Ratings from Staffing Data:
Overall Rating:

News Archive

U of I scientists show that tomato component reduces growth of prostate tumors in animal models

Years of research in University of Illinois scientist John Erdman's laboratory have demonstrated that lycopene, the bioactive red pigment found in tomatoes, reduces growth of prostate tumors in a variety of animal models. Until now, though, he did not have a way to trace lycopene's metabolism in the human body.

Bioactive lipid LPA mediates fibrogenesis in bleomycin mouse model of scleroderma

Amira Pharmaceuticals, Inc. announced today that their collaborators, Andrew Tager, M.D. and Flavia V. Castelino, M.D. of Massachusetts General Hospital, Harvard Medical School, will present a preclinical proof-of-concept study which demonstrates that the bioactive lipid lysophosphatidic acid (LPA), through its high affinity LPA1 receptor, is an important mediator of fibrogenesis in the bleomycin mouse model of scleroderma. Data will be presented as part of a poster session for the 1st Systemic Sclerosis World Congress to be held in Florence, Italy, February 11 to 13, 2010.

Study identifies new prognostic biomarker and therapeutic target for adult B-ALL

New insight into the aggressive behavior of certain adult B-acute lymphoblastic leukemias has provided researchers with a potential new prognostic biomarker and a promising new therapeutic target.

Foot fracture risk rises with childhood BMI

Body mass index is significantly associated with the risk for lower extremity fracture in children, US researchers report.

Read more Medical News

› Verified 7 days ago

Complaints, Fines and Penalties:

Number of Facility Reported Incidents0
Number of Substantiated Complaints0
Number of Fines0
Total Amount of Fines in Dollars$0
Number of Payment Denials0
Total Number of Penalties0

Patients' Stay Experience:

The resident survey data of St. Mary's Hospital is compared against the national average with the color code indicators: Better than National Average Worse than National Average

Experience MeasureProviderNational Avg.